Premier Alternatives

CoreMap

Burlington, MA · Founded 2016 · Privately Held (backing)

Developer of a diagnostic technology designed to enable curative treatment options. CoreMap is based in Burlington, MA and was founded in 2016. Its last reported valuation was $67.3 million in Feb 2022. It has raised $44.1 million across 3 recorded rounds; the latest was a $35.5 million early-stage round in Jun 2026.

Last reported valuation
$67.3M
Oct 2026
Priced at
—
Total raised
$44.1M
Last round
Early Stage VC
Jun 2026

CoreMap key facts

as of Oct 2026
  • Developer of a diagnostic technology designed to enable curative treatment options.
  • CoreMap is valued at approximately $67.3M as of Oct 2026 (last reported valuation).
  • It has raised $44.1M across 3 recorded rounds; the latest was Early Stage VC ($35.5M) in Jun 2026.
  • Notable investors include US National Science Foundation, Northpoint Capital Group, DRIVEN Accelerator Hub, Dudley Fund, Hula — 12 tracked in total.
  • CoreMap has filed 2 Form Ds with the SEC since 2022, most recently Jul 2025 ($6.8M sold to 19 investors).
  • Status: Privately Held (backing).
Last reported valuation
LOW confidence
$67.3M

CoreMap's last reported valuation, Feb 2022. Nothing priced has surfaced since.

set by last reported valuationas of Oct 2026question about this number?
Free account
More of CoreMap with a free account
  • ·The complete investor list: 12 names
  • ·Watch CoreMap: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

CoreMap funding rounds

3 rounds
Jun 2026Early Stage VC$35.5MSEC filing▮
Jul 2024Early Stage VC$6.8MSEC filing▮
Jan 2022Early Stage VC$23.2MSEC filing▮
Full funding history →

CoreMap valuation

CoreMap's last reported valuation was $67.3 million in Feb 2022. No priced round, secondary trade or fund mark has surfaced since.

How much has CoreMap raised?

CoreMap has raised $44.1 million across 3 recorded rounds since 2022. The largest was a $6.8 million early-stage round in Jul 2024; the most recent was a $35.5 million early-stage round in Jun 2026.

CoreMap has filed 2 Form Ds with the SEC since 2022, most recently in Jul 2025 ($6.8 million sold to 19 investors).

CoreMap investors

12 investors are on record for CoreMap, including US National Science Foundation, Northpoint Capital Group, DRIVEN Accelerator Hub and Dudley Fund. The early-stage round in Jun 2026 drew 73 investors.

About CoreMap

Developer of a diagnostic technology designed to enable curative treatment options. The company's technology uses a micro-electrode design that can map sequentially and overcome the two main obstacles of atrial fibrillation which have poor spatial resolution and inadequate sample density, enabling medical practitioners to improve outcomes for patients.

Sector
Healthcare
HQ
Burlington, MA, United States
Founded
2016
Employees
40
Ownership
Privately Held (backing)

Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.